0001209191-22-042573.txt : 20220719
0001209191-22-042573.hdr.sgml : 20220719
20220719164013
ACCESSION NUMBER: 0001209191-22-042573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220715
FILED AS OF DATE: 20220719
DATE AS OF CHANGE: 20220719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lachey Jennifer
CENTRAL INDEX KEY: 0001808322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 221091956
MAIL ADDRESS:
STREET 1: C/O KEROS THERAPEUTICS, INC.
STREET 2: 99 HAYDEN AVENUE, SUITE 120, BUILDING E
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Keros Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664710
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E)
STREET 2: LEDGEMONT TECHNOLOGY CENTER
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-513-8774
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E)
STREET 2: LEDGEMONT TECHNOLOGY CENTER
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-15
0
0001664710
Keros Therapeutics, Inc.
KROS
0001808322
Lachey Jennifer
C/O KEROS THERAPEUTICS, INC.
99 HAYDEN AVENUE, SUITE 120, BUILDING E
LEXINGTON
MA
02421
0
1
0
0
Chief Scientific Officer
Common Stock
2022-07-15
4
M
0
46034
0.30
A
141134
D
Common Stock
2022-07-15
4
S
0
46034
30.00
D
95100
D
Employee Stock Option (right to buy)
0.30
2022-07-15
4
M
0
46034
0.00
D
2028-03-25
Common Stock
46034
8755
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Immediately exercisable.
/s/ Keith Regnante, Attorney-in-Fact
2022-07-19